EPS International Korea Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

EPS International Korea General Information

Description

Provider of clinical research services intended to support drug development cycles. The company offers clinical trial execution, project operations, multi-regional clinical trials, drug registration support, clinical research management, and healthcare provision, enabling pharmaceutical and biotech companies to conduct clinical development across Northeast Asia.

Contact Information

Website
www.epsik.co.kr
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 507, Bluestone Tower
  • 9-16, Yeonmujang 5-gil
  • Seongdong-gu, Seoul
  • South Korea
+82
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Parent Company
Corporate Office
  • 507, Bluestone Tower
  • 9-16, Yeonmujang 5-gil
  • Seongdong-gu, Seoul
  • South Korea
+82

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

EPS International Korea Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore EPS International Korea‘s full profile, request access.

Request a free trial

EPS International Korea Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore EPS International Korea‘s full profile, request access.

Request a free trial

EPS International Korea FAQs

  • When was EPS International Korea founded?

    EPS International Korea was founded in 2011.

  • Where is EPS International Korea headquartered?

    EPS International Korea is headquartered in Seongdong-gu, South Korea.

  • What industry is EPS International Korea in?

    EPS International Korea’s primary industry is Drug Discovery.

  • Is EPS International Korea a private or public company?

    EPS International Korea is a Private company.

  • What is EPS International Korea’s current revenue?

    The current revenue for EPS International Korea is .

  • Who are EPS International Korea’s investors?

    EPS has invested in EPS International Korea.

  • When was EPS International Korea acquired?

    EPS International Korea was acquired on 13-Jul-2026.

  • Who acquired EPS International Korea?

    EPS International Korea was acquired by C&R Research.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process